This annual gathering of leaders at the Global Conference will examine policy priorities and investments that will be required in the wake of the COVID-19 pandemic to accelerate biomedical innovation, address public health challenges, and promote healthy aging. This off-the-record session allows participants—including members of Congress, administration officials, and CEOs of leading corporations—to engage in an informative, candid dialogue.